Yahoo
    HKSE - Delayed Quote HKD

    HUTCHMED (China) Limited (0013.HK)

    20.720 -0.060 (-0.29%)
    At close: 4:08:13 PM GMT+8
    Loading Chart for 0013.HK
    Chart Range Bar
    Interval:
    In partnership with ChartIQ

    Recent News

    HUTCHMED Announces Regulatory Filings Accepted for Review for ORPATHYS® plus TAGRISSO® in MET-Driven EGFR-Mutated Lung Cancer in Europe and Japan

    HUTCHMED Announces Regulatory Filings Accepted for Review for ORPATHYS® plus TAGRISSO® in MET-Driven EGFR-Mutated Lung Cancer in Europe and Japan
    GlobeNewswire 12h ago
    3 British Healthcare Stocks To Own In October 2026

    3 British Healthcare Stocks To Own In October 2026
    Simply Wall St. 2d ago
    HUTCHMED Announces Sovleplenib Granted US FDA Orphan Drug Designation for Primary Immune Thrombocytopenia

    HUTCHMED Announces Sovleplenib Granted US FDA Orphan Drug Designation for Primary Immune Thrombocytopenia
    GlobeNewswire 4d ago
    Save the Date: HUTCHMED to Host Expert Insights Event on Recent Savolitinib Clinical Data in Non-Small Cell Lung Cancer

    Save the Date: HUTCHMED to Host Expert Insights Event on Recent Savolitinib Clinical Data in Non-Small Cell Lung Cancer
    GlobeNewswire 6d ago
    HUTCHMED Highlights SANOVO Phase III Data for ORPATHYS® plus TAGRISSO® in First-Line EGFR-Mutated Lung Cancer Presented at ESMO Congress 2026

    HUTCHMED Highlights SANOVO Phase III Data for ORPATHYS® plus TAGRISSO® in First-Line EGFR-Mutated Lung Cancer Presented at ESMO Congress 2026
    GlobeNewswire 7d ago
    HUTCHMED Highlights SAFFRON Global Phase III Data Presented at ESMO Congress 2026 and Simultaneously Published in The New England Journal of Medicine

    HUTCHMED Highlights SAFFRON Global Phase III Data Presented at ESMO Congress 2026 and Simultaneously Published in The New England Journal of Medicine
    GlobeNewswire 7d ago
    What HUTCHMED (China) (AIM:HCM)'s GSK Licensing Deal Means For Shareholders

    What HUTCHMED (China) (AIM:HCM)'s GSK Licensing Deal Means For Shareholders
    Simply Wall St. 8d ago
    3 British Healthcare Stocks To Own In October 2026

    3 British Healthcare Stocks To Own In October 2026
    Simply Wall St. 9d ago
    HUTCHMED (China) (AIM:HCM) Closes GSK Deal, Is The Stock Still 38% Undervalued?

    HUTCHMED (China) (AIM:HCM) Closes GSK Deal, Is The Stock Still 38% Undervalued?
    Simply Wall St. 10d ago
    HUTCHMED Announces Closing of KRAS-EGFR-Antibody Conjugate Therapy License to GSK Outside China

    HUTCHMED Announces Closing of KRAS-EGFR-Antibody Conjugate Therapy License to GSK Outside China
    GlobeNewswire 12d ago
    HUTCHMED (AIM:HCM) Stock Looks Expensive Relative To Current Earnings

    HUTCHMED (AIM:HCM) Stock Looks Expensive Relative To Current Earnings
    Simply Wall St. 15d ago

    Related Tickers

    Mobilize your Website
    View Site in Mobile | Classic
    Share by: